Searched for
NEURO PSYCHIATRY MEDICINES
Highs & Lows: Could the microdosing of psychedelics be a key missing piece in the mental health jigsaw?A Netflix documentary highlights the re-evaluation of mind-expanding substances like LSD, once banned but now experiencing a scientific ren...- Healthcare stocks: Better to own a basket for a healthy portfolio? 15 healthcare stocks with an upside potential of up to 33%Four years ago, Covid brought hospital stocks to the limelight. Since then, corporate actions like mergers and takeovers have kept them in ...
- One possible headwind, but multiple tailwinds: 8 stocks from the healthcare ecosystem, 4 with ‘Buy’ & 4 with ‘Hold’ recommendationsWhen valuations across the stock markets are high, one should look for sectors with macro tailwinds. Sectors and stocks with structural tai...
- Will short-term headwinds impact long-term potential? 6 stocks from hospital sector with upside potential of up to 30%After outperforming the market, stocks from the healthcare sector or what is more commonly called hospital sector have gone into consolidat...
- Youth no longer shy of seeking psychiatric help: Gen Z demand for mental health drugs lifts sales 9 per cent to ₹11,774 croreConsider this. Neuro-psychiatry medicines are among the top 10 therapies in the country and the category is valued ₹11,774 crore, data from...
- Looking for a healthy portfolio amid volatility? 8 stocks from hospital space with upside scope of up to 27%One sector which has performed extremely well in the last two years has been hospital space. If one looks at the post listing performance o...
- Sun Pharma plans to focus on market share, sales in bid to outdo rivalsAs part of the strategy to stay ahead of its rivals in the highly fragmented domestic formulation business, Sun Pharma has embarked on majo...
- Did Covid leave you feeling lonely & confused? Recovery may be an uphill task but it is possibleThe GBD study revealed that around 35.4 per cent suffered cognitive problems.
- Sun Pharma enters licensing pact with Lundbeck to launch novel anti-depressant pill in IndiaVortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder (MDD) in adults.
- A long way to go! Every one in three Indians thinks psychiatrists are mentally illThe general public attitude towards the subject is correlated to religion, gender, education level and access to healthcare.
- Five things flyers must watch out for!Inside the cabin it's nice and cozy. But other dangers lurk in this pressurised metal tube for the flyers.
- Slowdown bout forces people to trim medical billsPeople have been popping fewer pills, reducing their visits to the doctor and going as far as discontinuing treatment when there is the sli...
Load More
